Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

The economic burden of COPD.

Sullivan SD, Ramsey SD, Lee TA.

Chest. 2000 Feb;117(2 Suppl):5S-9S.

PMID:
10673466
2.

The costs of treating COPD in the United States.

Strassels SA, Smith DH, Sullivan SD, Mahajan PS.

Chest. 2001 Feb;119(2):344-52.

PMID:
11171708
3.

Economic consequences of chronic obstructive pulmonary disease.

Strassels SA.

Curr Opin Pulm Med. 1999 Mar;5(2):100-4. Review.

PMID:
10813259
4.

Economic costs of diabetes in the US in 2002.

Hogan P, Dall T, Nikolov P; American Diabetes Association.

Diabetes Care. 2003 Mar;26(3):917-32.

PMID:
12610059
5.

Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.

Simoni-Wastila L, Blanchette CM, Qian J, Yang HW, Zhao L, Zuckerman IH, Pak GH, Silver H, Dalal AA.

Am J Geriatr Pharmacother. 2009 Oct;7(5):262-70. doi: 10.1016/j.amjopharm.2009.11.003.

PMID:
19948302
6.

The economic burden of mental illness.

Rice DP, Kelman S, Miller LS.

Hosp Community Psychiatry. 1992 Dec;43(12):1227-32.

PMID:
1459546
7.
8.

Epidemiology of chronic obstructive pulmonary disease (COPD).

Viegi G, Scognamiglio A, Baldacci S, Pistelli F, Carrozzi L.

Respiration. 2001;68(1):4-19. Review.

PMID:
11223724
9.

Economic burden of chronic obstructive pulmonary disease. Impact of new treatment options.

Friedman M, Hilleman DE.

Pharmacoeconomics. 2001;19(3):245-54. Review.

PMID:
11303413
10.

Costs of illness: United States, 1980.

Parsons PE, Lichtenstein R, Berki SE, Murt HA, Lepkowski JM, Stehouwer SA, Landis JR.

Natl Med Care Util Expend Surv C. 1986 Apr;(3):1-90.

PMID:
10313412
11.

Costs of occupational COPD and asthma.

Leigh JP, Romano PS, Schenker MB, Kreiss K.

Chest. 2002 Jan;121(1):264-72.

PMID:
11796461
12.

What is the cost to employers of direct medical care for chronic obstructive pulmonary disease?

Nurmagambetov T, Atherly A, Williams S, Holguin F, Mannino DM, Redd SC.

COPD. 2006 Dec;3(4):203-9.

PMID:
17361501
13.

The annual impact of seasonal influenza in the US: measuring disease burden and costs.

Molinari NA, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, Weintraub E, Bridges CB.

Vaccine. 2007 Jun 28;25(27):5086-96. Epub 2007 Apr 20.

PMID:
17544181
14.

The impact of aging and smoking on the future burden of chronic obstructive pulmonary disease: a model analysis in the Netherlands.

Feenstra TL, van Genugten ML, Hoogenveen RT, Wouters EF, Rutten-van Mölken MP.

Am J Respir Crit Care Med. 2001 Aug 15;164(4):590-6.

PMID:
11520721
15.

Total and state-specific medical and absenteeism costs of COPD among adults aged ≥ 18 years in the United States for 2010 and projections through 2020.

Ford ES, Murphy LB, Khavjou O, Giles WH, Holt JB, Croft JB.

Chest. 2015 Jan;147(1):31-45. doi: 10.1378/chest.14-0972.

PMID:
25058738
16.

Direct costs of COPD in the U.S.: an analysis of Medical Expenditure Panel Survey (MEPS) data.

Miller JD, Foster T, Boulanger L, Chace M, Russell MW, Marton JP, Menzin J.

COPD. 2005 Sep;2(3):311-8.

PMID:
17146996
17.

Cost of disorders of the brain in Europe 2010.

Gustavsson A, Svensson M, Jacobi F, Allgulander C, Alonso J, Beghi E, Dodel R, Ekman M, Faravelli C, Fratiglioni L, Gannon B, Jones DH, Jennum P, Jordanova A, Jönsson L, Karampampa K, Knapp M, Kobelt G, Kurth T, Lieb R, Linde M, Ljungcrantz C, Maercker A, Melin B, Moscarelli M, Musayev A, Norwood F, Preisig M, Pugliatti M, Rehm J, Salvador-Carulla L, Schlehofer B, Simon R, Steinhausen HC, Stovner LJ, Vallat JM, Van den Bergh P, van Os J, Vos P, Xu W, Wittchen HU, Jönsson B, Olesen J; CDBE2010Study Group.

Eur Neuropsychopharmacol. 2011 Oct;21(10):718-79. doi: 10.1016/j.euroneuro.2011.08.008. Epub 2011 Sep 15. Erratum in: Eur Neuropsychopharmacol. 2012 Mar;22(3):237-8. den Bergh, Peter Van [corrected to Van den Bergh, Peter].

PMID:
21924589
18.

Economic costs of anxiety disorders.

DuPont RL, Rice DP, Miller LS, Shiraki SS, Rowland CR, Harwood HJ.

Anxiety. 1996;2(4):167-72.

PMID:
9160618
19.

[Direct and indirect diabetes costs in the world].

Logminiene Z, Norkus A, Valius L.

Medicina (Kaunas). 2004;40(1):16-26. Review. Lithuanian.

20.

Economic and health consequences of COPD patients and their spouses in Denmark--1998-2010.

Løkke A, Hilberg O, Kjellberg J, Ibsen R, Jennum P.

COPD. 2014 Jun;11(3):237-46. doi: 10.3109/15412555.2013.839647. Epub 2013 Dec 19.

PMID:
24354969

Supplemental Content

Support Center